Early detection remains the most promising approach to improve long-term survival of
patients with ovarian cancer. In a five-center case-control study, serum proteomic expressions …

Purpose.— Clinical use of analytical tests to assess genomic variants in circulating tumor
DNA (ctDNA) is increasing. This joint review from the American Society of Clinical Oncology …

HUPO initiated the Plasma Proteome Project (PPP) in 2002. Its pilot phase has (1) evaluated
advantages and limitations of many depletion, fractionation, and MS technology platforms; (…

There is a substantial list of pre‐analytical variables that can alter the analysis of blood‐derived
samples. We have undertaken studies on some of these issues including choice of …

This work demonstrates that a full laboratory-quality immunoassay can be run on a
smartphone accessory. This low-cost dongle replicates all mechanical, optical, and electronic …

Purpose Mesothelin is currently considered the best available serum biomarker of malignant
pleural mesothelioma. To examine the diagnostic accuracy and use of serum mesothelin in …

Context.—Current tumor markers for ovarian cancer still lack adequate sensitivity and
specificity to be applicable in large populations. High-throughput proteomic profiling and …

PURPOSE This guideline provides recommendations for available tissue-based prostate
cancer biomarkers geared toward patient selection for active surveillance, identification of …

Clinical laboratory testing routinely provides actionable results, which help direct patient
care in the inpatient and outpatient settings. Since December 2019, a novel coronavirus (SARS-…

There is a wealth of knowledge in the field of in vitro diagnostics with regard to preanalytical
variables and their impact on the determination of peptide and protein analytes in human …